| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/23/2013 | US20130129847 Composition and Method for Reducing Post-Prandial Blood Glucose |
| 05/23/2013 | US20130129838 Nutritional compositions and methods for optimizing dietary acid-base potential |
| 05/23/2013 | US20130129833 Compositions for Regenerating Defective or Absent Myocardium |
| 05/23/2013 | US20130129815 Liposomal formulation for oral administration of glutathione (reduced) via gel capsule |
| 05/23/2013 | US20130129783 Use of botulinum neurotoxin to alleviate various disorders |
| 05/23/2013 | US20130129751 Method for treating prostatitis utilizing pore-forming protein proaerolysin |
| 05/23/2013 | US20130129733 Humanized anti-egfl7 antibodies and methods using same |
| 05/23/2013 | US20130129722 Methods for Treating Cancer by Administering an Anti-Ang-2 Antibody |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129706 Crotoxin Administration for Cancer Treatment and Pain Relief |
| 05/23/2013 | US20130129702 Materials and methods for prevention and treatment of rna viral diseases |
| 05/23/2013 | US20130129699 Botulinum toxin compositions and methods |
| 05/23/2013 | US20130129698 Conjugated blood coagulation factor viia |
| 05/23/2013 | US20130129697 Enhanced Staphylolytic Activity of the Staphylococcus aureus Bacteriophage vB_SauS-philPLA88 Virion-Associated Peptidoglycan Hydrolase HydH5: Fusions, Deletions and Synergy with LysH5 |
| 05/23/2013 | US20130129691 Compositions For The Treatment Of Skin Conditions, Disorders Or Diseases And Methods Of Making And Using The Same |
| 05/23/2013 | US20130129689 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 05/23/2013 | US20130129680 Method for treating hepatitis c virus infection using quercetin-containing compositions |
| 05/23/2013 | US20130129679 Interferon beta as antibacterial agents |
| 05/23/2013 | US20130129678 Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer |
| 05/23/2013 | US20130129677 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
| 05/23/2013 | US20130129676 Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection |
| 05/23/2013 | US20130129675 Interferon therapies in combination with blockade of stat3 activation |
| 05/23/2013 | US20130129674 Il-12 formulations for enhancing hematopoiesis |
| 05/23/2013 | US20130129673 Use of endogenous antioxidant proteins in the treatment of stroke |
| 05/23/2013 | US20130129671 Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus |
| 05/23/2013 | US20130129670 Macrophage activating factor for use in the treatment of chronic fatigue syndrome (cfs) and cfs-related diseases and disorders |
| 05/23/2013 | US20130129669 Stable Formulations of Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor |
| 05/23/2013 | US20130129621 Integrin Receptor Antagonists and Their Methods of Use |
| 05/23/2013 | US20130129617 Method for Treating Psoriatic Arthritis By Administering An Anti-IL-12 Antibody |
| 05/23/2013 | US20130125886 Method of preventing adverse effects by glp-1 |
| 05/23/2013 | US20130125879 Microparticle formulation for pulmonary drug delivery of anti infective molecule for treatment of infectious diseases |
| 05/23/2013 | CA2856329A1 Compositions and methods for treating glioma |
| 05/23/2013 | CA2856074A1 Autoclavable suspensions of cyclosporin a form 2 |
| 05/23/2013 | CA2856044A1 Sustained action formulation of cyclosporin form 2 |
| 05/23/2013 | CA2856034A1 Cyclosporine a form 2 and method of making same |
| 05/23/2013 | CA2855916A1 Polymyxin derivatives |
| 05/23/2013 | CA2855818A1 Methods of treating cancer |
| 05/23/2013 | CA2855770A1 Pegylated c-peptide |
| 05/23/2013 | CA2855753A1 Cationic antibacterial composition |
| 05/23/2013 | CA2855749A1 Polymer protein microparticles |
| 05/23/2013 | CA2855719A1 Apoaequorin for reducing neuronal injury due to ischemia |
| 05/23/2013 | CA2855675A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
| 05/23/2013 | CA2855653A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | CA2855545A1 Oral leptin formulations and uses thereof |
| 05/23/2013 | CA2854882A1 Medicament for therapeutic treatment and/or improvement of sepsis |
| 05/23/2013 | CA2854809A1 Compositions and methods for treating autoimmune and inflammatory disorders |
| 05/23/2013 | CA2852133A1 Soluble mediator |
| 05/23/2013 | CA2847246A1 Glucagon superfamily peptides exhibiting glucocorticoid receptor activity |
| 05/23/2013 | CA2845637A1 Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer |
| 05/22/2013 | EP2594644A1 Method for preparing novel hipsc by means of mirna introduction |
| 05/22/2013 | EP2594643A1 Method for producing novel hipsc by means of sirna introduction |
| 05/22/2013 | EP2594585A1 Methods of treating pain and inflammation in neuronal tissue using IL-31 antagonists |
| 05/22/2013 | EP2594583A1 Transferrin variants and conugates |
| 05/22/2013 | EP2594579A1 Truncated human papillomavirus type 58 l1 protein |
| 05/22/2013 | EP2594283A1 Aprotinin-based aerosol preparation for the treatment of viral respiratory infections |
| 05/22/2013 | EP2594282A1 Lactoferrin and the white matter |
| 05/22/2013 | EP2594281A1 Insulin-lipid complex, preparation method therefor, and preparation thereof |
| 05/22/2013 | EP2594280A1 Activin neutralisers and uses thereof for treatment of diseases associated with aberrant "host defence response" activation |
| 05/22/2013 | EP2594279A1 Tissue protective peptides and uses thereof |
| 05/22/2013 | EP2594274A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 05/22/2013 | EP2593796A2 Bacterial nitroreductase enzymes and methods relating thereto |
| 05/22/2013 | EP2593570A2 Fermented soya based mixture comprising isoflavones- aglicones, equol and lunasil, process for the preparation and uses thereof in food, medical and cosmetic fields |
| 05/22/2013 | EP2593131A2 Methods and compositions for cns delivery of iduronate-2-sulfatase |
| 05/22/2013 | EP2593130A2 Stabilized factor viii variants |
| 05/22/2013 | EP2593129A2 Use of the pat nonapeptide in treating and preventing neurodegenerative diseases |
| 05/22/2013 | EP2593128A1 Humanized antibodies targeting the ec1 domain of cadherin-11 and related compositions and methods |
| 05/22/2013 | EP2593127A1 Anti-angiogenic agent and method of using such agent |
| 05/22/2013 | EP2593126A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 05/22/2013 | EP2593125A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| 05/22/2013 | EP2593124A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 05/22/2013 | EP2593123A1 Romidepsin solid forms and uses thereof |
| 05/22/2013 | EP2593122A1 Peptide for use in the treatment of breast cancer and/or bone metastases |
| 05/22/2013 | EP2593121A2 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| 05/22/2013 | EP2593120A1 Method of treatment of hiv or aids |
| 05/22/2013 | EP2593105A1 Palatable pharmaceutical composition comprising vx-950 |
| 05/22/2013 | EP2593088A1 Microparticles comprising a small heat-shock protein |
| 05/22/2013 | EP2593084A2 A liquid formulation of long-acting human growth hormone conjugate |
| 05/22/2013 | EP2593081A1 Ferrimannitol-ovalbumin tablet composition |
| 05/22/2013 | EP2047867B1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 05/22/2013 | CN1732014B Templated native silk smectic gels |
| 05/22/2013 | CN1729012B Composition for treating solid tumors |
| 05/22/2013 | CN1643143B Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 05/22/2013 | CN103119057A Amide-based insulin prodrugs |
| 05/22/2013 | CN103119055A Pegylated C-Peptide |
| 05/22/2013 | CN103119054A VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof |
| 05/22/2013 | CN103119052A Peptide derivatives, preparation thereof and uses thereof |
| 05/22/2013 | CN103118698A Neuregulin isoforms, neuregulin polypeptides and uses thereof |
| 05/22/2013 | CN103118697A Immunogenic compositions and methods for treating neoplasia |
| 05/22/2013 | CN103118696A Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl tRNA synthetases |
| 05/22/2013 | CN103118695A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| 05/22/2013 | CN103118694A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases |
| 05/22/2013 | CN103118693A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases |
| 05/22/2013 | CN103118692A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
| 05/22/2013 | CN103118691A Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with NOD2 agonist or cultured product thereof |
| 05/22/2013 | CN103118671A Transdermal therapeutic system for the administration of peptides |
| 05/22/2013 | CN103118664A Cyclosporine emulsion |
| 05/22/2013 | CN103114117A Method for preparing fish egg sugar protein with anti-osteoporosis effect |
| 05/22/2013 | CN103114115A Method for preparing recombinant human granulocyte colony stimulating factors screened by microorganisms, and medicament composition and preparation thereof |
| 05/22/2013 | CN103113473A TAT-LBD-NEP1-40 fusion protein, construction method and application thereof |
| 05/22/2013 | CN103113472A Fusion peptide with myocardial preservation function as well as preparation method and application thereof |